These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2442994)

  • 1. Comparison of ethmozine to propranolol and the combination for ventricular arrhythmias.
    Butman SM; Knoll ML; Gardin JM
    Am J Cardiol; 1987 Sep; 60(7):603-7. PubMed ID: 2442994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
    Pratt CM; Butman SM; Young JB; Knoll M; English LD
    Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethmozine for ventricular premature complexes.
    Gear K; Marcus FI; Huang SK; Fenster PE; Appleton C; Moeller V; Renaud G; Serokman R
    Am J Cardiol; 1986 Apr; 57(11):947-9. PubMed ID: 2421571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethmozine suppression of single and repetitive ventricular premature depolarizations during therapy: documentation of efficacy and long-term safety.
    Pratt CM; Yepsen SC; Taylor AA; Mason DT; Miller RR; Quinones MA; Lewis RA
    Am Heart J; 1983 Jul; 106(1 Pt 1):85-91. PubMed ID: 6346845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.
    Pratt CM; Young JB; Francis MJ; Taylor AA; Norton HJ; English L; Mann DE; Kopelen H; Quinones MA; Roberts R
    Circulation; 1984 Feb; 69(2):288-97. PubMed ID: 6360413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum digoxin concentrations during ethmozine antiarrhythmic therapy.
    Kennedy HL; Sprague MK; Redd RM; Wiens RD; Blum RI; Buckingham TA
    Am Heart J; 1986 Apr; 111(4):667-72. PubMed ID: 2420164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerance of Ethmozine (moricizine HCl) in placebo-controlled trials.
    Morganroth J; Pratt CM; Kennedy HL; Singh SN; Platt ML; Baker BJ; Mason DT
    Am J Cardiol; 1987 Oct; 60(11):48F-51F. PubMed ID: 3310585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative effectiveness of ethmozine, mexitil, quinidine and obsidan in the treatment of ventricular rhythm disorders].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1981 Oct; 21(10):59-64. PubMed ID: 6170776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. The Cardiac Arrhythmia Pilot Study (CAPS) investigators.
    Am J Cardiol; 1988 Apr; 61(10):704-13. PubMed ID: 2451414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
    Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
    Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
    Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
    Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of moricizine in malignant ventricular arrhythmias.
    Horowitz LN
    Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of prolonged ethmozine treatment in patients with ventricular arrhythmias].
    Kurbanov RD; Mazur NA
    Kardiologiia; 1983 Nov; 23(11):51-5. PubMed ID: 6197557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of a twice-daily dosing regimen for moricizine (ethmozine).
    Morganroth J
    Am Heart J; 1985 Dec; 110(6):1188-92. PubMed ID: 3907314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose effect of moricizine on suppression of ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1990 Feb; 65(8):26D-31D; discussion 68D-71D. PubMed ID: 1689534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of baseline characteristics to suppression of ventricular arrhythmias during placebo and active antiarrhythmic therapy in patients after myocardial infarction.
    Anderson JL; Hallstrom AP; Griffith LS; Ledingham RB; Reiffel JA; Yusuf S; Barker AH; Fowles RE; Young JB
    Circulation; 1989 Mar; 79(3):610-9. PubMed ID: 2465099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.